Market Place
Sourcing Support
All News #Library
Others
Novartis buys Blackstone`s Anthos for up to $3.1 billion
12 Feb 2025 //
REUTERS
Novartis Buys Anthos For $925M To Boost Cardiovascular Pipeline
11 Feb 2025 //
GLOBENEWSWIRE
Anthos Therapeutics Appoints Will Kane as President & CFO Ramanan
31 Oct 2024 //
GLOBENEWSWIRE
Anthos Therapeutics Names New General Counsel And CHRO
10 Oct 2024 //
GLOBENEWSWIRE
Anthos Unveils AZALEA-TIMI 71 Study Analysis On Low Periprocedural Bleeding
02 Sep 2024 //
BUSINESSWIRE
Anthos Therapeutics Announces Appointment of Bill Meury as CEO
22 Apr 2024 //
GLOBENEWSWIRE
Anthos Supported Global Survey of 3000+ Patients Prescribed Anticoagulants
26 Jun 2023 //
GLOBENEWSWIRE
Regulatory Authorities in China and Japan Approve Clinical Trials for Anthos
08 Jun 2023 //
GLOBENEWSWIRE
New Assessment Scale to Measure Adherence to Oral Anticoagulants Based on Impact
09 May 2023 //
GLOBENEWSWIRE
US FDA grants Fast Track status for Anthos Therapeutics’ abelacimab
09 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Anthos Launches Second Phase 3 Clinical Trial of Abelacimab
25 Aug 2022 //
GLOBENEWSWIRE
Four New Sets of PC Data Further Expands the Evidence Supporting Abelacimab
13 Jul 2022 //
PRNEWSWIRE
Anthos Announces that Abelacimab has Received FDA FTD for Thrombosis
11 Jul 2022 //
BIOSPACE
Anthos Therapeutics to Host Discussion with Global Experts at 2022 BIO
13 Jun 2022 //
PRNEWSWIRE
Anthos Therapeutics Appoints Drew Young as CCO and Head of Patient Experience
26 May 2022 //
PRNEWSWIRE
Abelacimab: First Factor XI Inhibitor to Enroll Patients in PIII Trial
05 May 2022 //
PRNEWSWIRE
Anthos Therapeutics Partners with Lonza to Develop and MFG Abelacimab
11 Jun 2020 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.